(Q84519490)
Statements
Phase II trial of weekly alternating sequential BIBF 1120 and afatinib for advanced colorectal cancer (English)
Olivier Bouche
Frederique Maindrault-Goebel
Michel Ducreux
Gerard Lledo
Peter Stopfer
Nadia Amellal
Michael Merger
Aimery De Gramont